已收盘 07-02 16:00:00 美东时间
+0.420
+1.78%
Artivion, Inc. (NYSE:AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the premarket approval application (PMA) for the AMDS Hybrid Prosthesis ("AMDS"). The approval covers acute Debakey Type...
06-29 19:13
ATLANTA, May 18, 2026 Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it has completed the acquisition of its long...
05-18 19:00
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
多只绩优股狂飙!Rackspace周内狂涨210%,DigitalOcean周涨近60%股价再创新高;AI“带飞”建筑巨头业绩!斯特林建筑周涨逾58%>>
05-09 10:06
Needham analyst Mike Matson maintains Artivion (NYSE:AORT) with a Buy and lowers the price target from $58 to $44.
05-08 18:48
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson May 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Applied Materials, McDonald's and McKesson on Friday. HIGHLIGHTS * Applied Materials Inc AMAT.O : Berenb
05-08 15:12
Artivion Inc. (($AORT)) has held its Q1 earnings call. Read on for the main hig...
05-08 08:25
Artivion ( ($AORT) ) has shared an announcement. On May 7, 2026, Artivion repor...
05-08 05:16
Artivion shares are trading lower after the company reported Q1 financial resul...
05-08 05:15